3rd Cancer Targets and Therapeutics

Venue: Red Rock Casino, Resort & Spa

Location: Las Vegas, NV, -

Event Date/Time: Feb 27, 2012 End Date/Time: Feb 28, 2012
Report as Spam


With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. GTC's 3rd Cancer Targets and Therapeutics to be held Feb 27-28, 2012 at the Red Rock Casino, Resort & Spa in Las Vegas, NV examines new and emerging targets and therapeutics in the area of cancer research. Speakers at the event provide case studies of emerging targets in order to address some of the issues surrounding target-based drug discovery and development.

Below are the sessions for this year's conference. Check back soon for more updates!
Investments, Partnerships & Acquisitions
Recent Models of Deals and Trends in Immunotherapeutics
Scientific and Regulatory Updates
Innovative Partnering & Licensing Strategies
Technology Applications in Immunotherapeutics
Emerging Antibody Engineering Technologies
Recent Advances and Developments in Immunotherapeutics

Panel: Investments and Partnership Opportunities in the Immunotherapeutics Space
Panel: Strategic Trends in Immunotherapeutics
Panel: Future of Bi-specific Antibodies

This conference is also part of the Novel Immunotherapeutics Summit, which consists of this track and three other tracks:
1) 4th Immunotherapeutics and Immunomonitoring
2) 10th Cytokines and Inflammation
3) Allergy Drug Discovery and Development

We look forward to seeing you at the conference!

Conference Date: Feb 27-28, 2012
Venue: Red Rock Casino, Resort & Spa, 11011 W. Charleston, Las Vegas, NV 89135

Event Link: http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=3rd%20Cancer%20Targets%20and%20Therapeutics&cid=60